Cargando…
Microneedle-based ocular drug delivery systems – recent advances and challenges
Eye diseases and injuries constitute a significant clinical problem worldwide. Safe and effective delivery of drugs to the eye is challenging mostly due to the presence of ocular barriers and clearance mechanisms. In everyday practice, the traditional eye drops, gels and ointments are most often use...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623140/ https://www.ncbi.nlm.nih.gov/pubmed/36348935 http://dx.doi.org/10.3762/bjnano.13.98 |
_version_ | 1784821930425057280 |
---|---|
author | Gadziński, Piotr Froelich, Anna Wojtyłko, Monika Białek, Antoni Krysztofiak, Julia Osmałek, Tomasz |
author_facet | Gadziński, Piotr Froelich, Anna Wojtyłko, Monika Białek, Antoni Krysztofiak, Julia Osmałek, Tomasz |
author_sort | Gadziński, Piotr |
collection | PubMed |
description | Eye diseases and injuries constitute a significant clinical problem worldwide. Safe and effective delivery of drugs to the eye is challenging mostly due to the presence of ocular barriers and clearance mechanisms. In everyday practice, the traditional eye drops, gels and ointments are most often used. Unfortunately, they are usually not well tolerated by patients due to the need for frequent use as well as the discomfort during application. Therefore, novel drug delivery systems with improved biopharmaceutical properties are a subject of ongoing scientific investigations. Due to the developments in microtechnology, in recent years, there has been a remarkable advance in the development of microneedle-based systems as an alternative, non-invasive form for administering drugs to the eye. This review summarizes the latest achievements in the field of obtaining microneedle ocular patches. In the manuscript, the most important manufacturing technologies, microneedle classification, and the research studies related to ophthalmic application of microneedles are presented. Finally, the most important advantages and drawbacks, as well as potential challenges related to the unique anatomy and physiology of the eye are summarized and discussed. |
format | Online Article Text |
id | pubmed-9623140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Beilstein-Institut |
record_format | MEDLINE/PubMed |
spelling | pubmed-96231402022-11-07 Microneedle-based ocular drug delivery systems – recent advances and challenges Gadziński, Piotr Froelich, Anna Wojtyłko, Monika Białek, Antoni Krysztofiak, Julia Osmałek, Tomasz Beilstein J Nanotechnol Review Eye diseases and injuries constitute a significant clinical problem worldwide. Safe and effective delivery of drugs to the eye is challenging mostly due to the presence of ocular barriers and clearance mechanisms. In everyday practice, the traditional eye drops, gels and ointments are most often used. Unfortunately, they are usually not well tolerated by patients due to the need for frequent use as well as the discomfort during application. Therefore, novel drug delivery systems with improved biopharmaceutical properties are a subject of ongoing scientific investigations. Due to the developments in microtechnology, in recent years, there has been a remarkable advance in the development of microneedle-based systems as an alternative, non-invasive form for administering drugs to the eye. This review summarizes the latest achievements in the field of obtaining microneedle ocular patches. In the manuscript, the most important manufacturing technologies, microneedle classification, and the research studies related to ophthalmic application of microneedles are presented. Finally, the most important advantages and drawbacks, as well as potential challenges related to the unique anatomy and physiology of the eye are summarized and discussed. Beilstein-Institut 2022-10-24 /pmc/articles/PMC9623140/ /pubmed/36348935 http://dx.doi.org/10.3762/bjnano.13.98 Text en Copyright © 2022, Gadziński et al. https://creativecommons.org/licenses/by/4.0/This is an open access article licensed under the terms of the Beilstein-Institut Open Access License Agreement (https://www.beilstein-journals.org/bjnano/terms/terms), which is identical to the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ). The reuse of material under this license requires that the author(s), source and license are credited. Third-party material in this article could be subject to other licenses (typically indicated in the credit line), and in this case, users are required to obtain permission from the license holder to reuse the material. |
spellingShingle | Review Gadziński, Piotr Froelich, Anna Wojtyłko, Monika Białek, Antoni Krysztofiak, Julia Osmałek, Tomasz Microneedle-based ocular drug delivery systems – recent advances and challenges |
title | Microneedle-based ocular drug delivery systems – recent advances and challenges |
title_full | Microneedle-based ocular drug delivery systems – recent advances and challenges |
title_fullStr | Microneedle-based ocular drug delivery systems – recent advances and challenges |
title_full_unstemmed | Microneedle-based ocular drug delivery systems – recent advances and challenges |
title_short | Microneedle-based ocular drug delivery systems – recent advances and challenges |
title_sort | microneedle-based ocular drug delivery systems – recent advances and challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623140/ https://www.ncbi.nlm.nih.gov/pubmed/36348935 http://dx.doi.org/10.3762/bjnano.13.98 |
work_keys_str_mv | AT gadzinskipiotr microneedlebasedoculardrugdeliverysystemsrecentadvancesandchallenges AT froelichanna microneedlebasedoculardrugdeliverysystemsrecentadvancesandchallenges AT wojtyłkomonika microneedlebasedoculardrugdeliverysystemsrecentadvancesandchallenges AT białekantoni microneedlebasedoculardrugdeliverysystemsrecentadvancesandchallenges AT krysztofiakjulia microneedlebasedoculardrugdeliverysystemsrecentadvancesandchallenges AT osmałektomasz microneedlebasedoculardrugdeliverysystemsrecentadvancesandchallenges |